DCs and macrophages are highly hetero geneous cells (Vremec and Shortman, 1997; Shortman and Liu, 2002; Gordon and Taylor, 2005; ZieglerHeitbrock et al., 2010) . Their myriad subtypes exhibit a blend of shared and unique functions that tailor their abilities to regulate innate and adaptive immune responses. In mouse LNs, conventional DCs include the CD8 + and CD11b + subgroups, the latter sub divided based on CD4 expression (Vremec et al., 2000; Allan et al., 2003; Belz et al., 2004; Hildner et al., 2008) . Recent DC immigrants populating skin draining LNs (DLNs) include Langerhans cells and CD8  CD103 + dermal DCs (Randolph et al., 2008; Bedoui et al., 2009 ). An additional subset, plasmacytoid DCs (pDCs) are copious producers of type I IFNs (Swiecki and Colonna, 2010) . Microbial infec tions typically increase DC numbers in the DLN, and induce the differentiation of inflam matory DCs (Serbina et al., 2003) .
Macrophage subtypes are less clearly estab lished than DC subtypes, but can be delineated based on anatomical location (e.g., marginal zone splenic macrophages) or expression of cell surface receptors (e.g., CD169, mannose re ceptor, MARCO, and dectin1; Taylor et al., 2005) . Within the LN, both subcapsular sinus (SCS) and medullary macrophages express sialoadhesin (CD169), with the latter distin guished by coexpression of F4/80 (Phan et al., 2009) . The inflammatory milieu heavily influ ences the differentiation state of macrophages (Serbina et al., 2008; Liu et al., 2009) .
LN macrophages have recently been the subject of intense investigation because of their rapid and efficient uptake of lymphborne par ticles deposited into the LN SCS. After antigen capture, SCS macrophages can relay antigen to follicular B cells (Carrasco and Batista, 2007; Junt et al., 2007; Phan et al., 2007) , a step that promotes the affinity maturation of antibodies To better understand the priming of antiviral CD8 + T cells in vivo, we have combined intravital multiphoton microscopy (MPM) with other approaches to dissect mechanisms controlling T cell activation during viral in fection. We show that CD8 + T cells interact with both vi rally infected macrophages and DCs in vivo in the DLN. Macrophage interactions, however, cannot fully prime antiviral CD8 + T cells. To optimize priming, CD8 + T cells use chemokines to guide them to DCs in vivo, and neu tralizing these chemokines diminishes the antiviral CD8 + T cell response.
RESULTS

Definition of a macrophage-rich region (MRR) of the inguinal LN
Visualizing macrophages and DCs in vivo using MPM ne cessitates the unambiguous, simultaneous fluorescent detec tion of both cell populations. Although CD11ceYFP reporter mice allow DC analysis via MPM (Lindquist et al., 2004) , no red fluorescent counterpart exists for macrophages. Gretz et al. (2000) showed that s.c. injected dextran ≥70 kD was initially excluded from cortical areas of the LN but flowed into the subcapsular and medullary sinuses, where it accumu lated in unidentified phagocytic cells. Sub sequently, Carrasco and Batista (2007) identified this region (Abs; Phan et al., 2009) . As SCS macrophages express lower levels of several proteases involved in proteolytic degradation of phagocytosed antigen, Phan et al. (2007) suggested that their function may be to maintain a reservoir of antigen for relay to LN B cells. However, many SCS macrophages are not located above B cell follicles, but rather above the T cell zone in the peripheral interfollicular regions (PIRs) of the node (Hickman et al., 2008) , suggesting their participation in T cell responses.
As with other particulate antigens, virions trafficking to the LNs via the lymphatics are internalized by SCS macrophages (Norbury et al., 2002; Junt et al., 2007; Hickman et al., 2008; Iannacone et al., 2010) . Both vaccinia virus (VV) and vesicular stomatitis virus readily infect nodal macrophages, which ac count for up to 85% of virusinfected LN cells within a few hours of infection (Norbury et al., 2002; Hickman et al., 2008) . Functionally, SCS macrophages limit vesicular stomatitis vire mia and dissemination (Junt et al., 2007) , and are a critical source of type I IFNs (Iannacone et al., 2010) . Although macro phages express the appropriate machinery for T cell activation, numerous studies have shown through in vivo ablation or ex vivo isolation that DCs prime CD8 + T cells after viral infection (Allan et al., 2003; Probst et al., 2005; Ciavarra et al., 2006; Kassim et al., 2006) . It is currently unknown whether CD8 + T cells interact with infected LN macrophages. Additionally, because infected macrophages and DCs are inti mately intermingled in the PIRs, it is unclear how T cells se lect DCs for priming over the more numerous macrophages. 
CD8 + T cells interact with V V-infected macrophages and DCs in vivo
Previously, we showed that CD8 + T cells in virusDLNs form intimate, enduring antigenspecific interactions with virusinfected cells, leading to T cell activation (Norbury et al., 2002; Hickman et al., 2008) . Notably, interactions oc curred in a relatively small subregion of the LN, the PIR, and as a macrophagerich area. Therefore, to visualize macro phages, we injected mice s.c. with 70 kD tetramethylrhoda mine dextran (red fluorescent) and examined excised nodes at 30-45 min after injection by immunohistochemistry and flow cytometry (Fig. 1) .
Dextran + cells were clearly visible in frozen sections at the periphery of the LN, both in the SC and medullary sinuses, as well as in the interfollicular channels identified via staining of the LN stroma with ERTR7 (Fig. 1 A) . Dextran + cells composed a distinct area of the cortical ridge (CR) region of the LN (Katakai et al., 2004 ) between the T cell zone and B cell follicles. Additional staining clearly identified the dex tran + cells as SCS and medullary macrophages (Fig. 1, B and C) , indicated by expression of CD11b and CD169 (SCS mac rophages) and F4/80 on medullary macrophages (Phan et al., 2009) . Although the overwhelming majority of con ventional (CD11c + ) DCs do not endocytose dextran (visual ized by MPM; Fig. 1 , D and E), we detected a minor population of dextran + CD11b + CD11c + DCs using flow cytometry ( Fig. 1 C) . Conventional DCs are positioned on either side of the dextran + cells in the CR, clearly distinct from macrophages using MPM (Fig. 1, D and E; and Videos 1 and 2). This region of dense dextran + macrophages over laps but is not identical to either the PIR or CR and repre sents the MRR.
Together, these data support the use of dextran endocyto sis for the in vivo labeling of LN macrophages in the sinuses and MRR.
SCS and medullary macrophages become infected by lymph-borne virus
We previously reported that SCS macrophages are the pre dominant infected cell in the DLN after s.c. VV injection (Norbury et al., 2002; Hickman et al., 2008) . Now other lymphborne viruses have been shown to infect or accumu late in SCS macrophages (Hsu et al., 2009; Gonzalez et al., 2010) . Although these studies relied exclusively on CD169 to identify SCS macrophages, it is now clear that medullary macrophages also express this marker (Phan et al., 2009) .
Thus, we reexamined LNs (Fig. 2 ) using CD169 and F4/80 in flow cytometry to distinguish macrophage popula tions 8-10 h after infecting mice s.c. with a recombinant VV (rVV) expressing a red fluorescent protein (VVNP SmCherry; Table I ). This revealed that >90% of VV infected LN cells were CD169 + or CD11c high/intermediate (Fig. 2, A-C) . Approximately 15% of infected cells were DCs, with the remainder being CD169 high/intermediate . As ex pected, almost all of the CD169 + cells were also CD11b + , with 56% being F4/80 dim SCS macrophages (Fig. 2 B , far right) and 38% being F4/80 + medullary macrophages.
To confirm this finding, we performed wholemount F4/80 staining of nodes removed 10 h post infection (hpi; Fig. 2 D) . We detected a substantial number of F4/80 + , dextran + VVinfected cells in the LN. Thus, both medullary macrophages and SCS macrophages are robustly infected by virus draining to the LN. Clarke et al., 2000) . At 10 hpi, we imaged excised inguinal LNs via confocal microscopy ( Fig. 3 A) , or inguinal LNs in living animals using MPM (Fig. 3 B) . In uninfected nodes or nodes infected with a control rVV lacking SIIN FEKL, few OTI cells are present in the PIR (Video 3). After VV infection with a SIINFEKLcontaining virus (VVNPS mCherry [red]), we commonly observed OTI cells contacting infected DCs (Fig. 3 , A and B; and Video 4). We also identified OTI cells interacting with likely unin fected DCs (we cannot rigorously exclude expression of fluorescent protein below detection limits) and infected eYFP  cells identified as macrophages in other analyses antigen was required for T cell accumulation in the PIR and for sustained DC-T cell interactions (Hickman et al., 2008) . However, we were technically unable to simultaneously identify virusinfected cells and DCs by MPM because of spectral overlap of the fluorescent proteins used to visualize generation of bonemarrow chimeras, our shortterm assays were performed simply with transgenic animals. Thus, to mea sure T cell activation in the absence of DCs, we adoptively transferred OTI cells (because of the potential effects of DTx on autologous T cells in DTR mice, which can express CD11c [and DTR] upon activation; Jung et al., 2002) , administered DTx, and examined OTI cell proliferation in rVVinfected LNs (Fig. 4 , A and E). DTx treatment greatly reduced (but did not eliminate) OTI cell proliferation in response to VV encoded antigen. We next analyzed several common T cell activation markers (Fig. 4 , C-E). Macrophageactivated T cells failed to normally upregulate CD25 or downregulate CD62L (Fig. 4 , C and D). Although CD69 was induced in OTI cells, it was dysregulated in comparison to cells activated in the pres ence of DCs (at 36 h there was less downregulation compared with WT; Fig. 4 E), and CD69 was not upregulated at all under the same circumstances in different TCR transgenic T cells (unpublished data). Reducing the number of OTI cells transferred failed to restore their normal activation phenotype (unpublished data), indicating that this phenomenon is unlikely to be an artifact of using a high precursor frequency of TCR transgenic cells (Badovinac et al., 2007) . Such macrophage activatedCD8 + T cells demonstrated functional defects as well (Fig. 4 , F-I). OTI cells were transferred into CD11cDTReGFP mice that received DTx 12 h. before infection with VVOva (Table I) . In untreated mice, 90% of (Video 4). We routinely identified multiple examples of each interaction occurring in individual LNs (Fig. 3 B) .
We next labeled macrophages in CD11ceYFP mice via s.c. dextran injection. Few OTI cells were located at the pe riphery of the uninfected LNs, or in nodes infected with con trol virus (Fig. 3 C left and center panels and Video 3). In contrast, infection with VV expressing cognate antigen in duced OTI cells to localize to the PIR (Fig. 3 C, Video 3, and Video 5). Most (but not all) OTI cells were excluded from the MRR (Fig. 3 C, schematic, far right).
Collectively, these data indicate that although most CD8 + T cells interact with infected and uninfected DCs, they can and do interact with VVinfected PIR macrophages under normal circumstances.
V V-infected macrophages stimulate T cell division but not activation
What happens when CD8 + T cells interact exclusively with infected macrophages? We forced T cells to use infected macrophages as APCs, using CD11cdiphtheria toxin (DTx) receptor (DTR)eGFP mice (Jung et al., 2002 ) that were pre viously used for ex vivo analyses of immune responses to other viruses (Ciavarra et al., 2005; Probst et al., 2005; Kassim et al., 2006) . In this system, administration of DTx results in DC ablation in vivo, leaving macrophages as the only infected cell type in the DLNs. Although longterm DC depletion requires which is decreased viral infection/antigen presentation in the DCdepleted LNs. To analyze this, we infected DTXtreated CD11cDTReGFP mice or nontreated WT mice with VVNPSeGFP and visualized infected cells by MPM (Fig. 5 A) . Numerous VVinfected cells were present just beneath the SCS of the DLN in untreated or DTxtreated animals (Fig. 5 A) . Most infected cells were macrophages (Video 6), as indicated by in vivo endocytosis of fluorescent dextran administered s.c., and confirmed by CD11b + staining (Fig. 5 B) or F4/80 staining (Fig. 5 C) of wholemount LN sections. Using flow cytometry, we found that almost all of the infected LN cells recovered from DTxtreated mice (10 fold fewer than recovered from untreated mice) were CD11b + , CD169 + , F4/80 + medullary macrophages (Fig. 5 D) .
To examine the ability of DTxresistant macrophages to present rVV antigens, we infected mice with a rVV express ing a highly fluorescent fusion protein (Venusubiquitin SIINFEKL) that generates large amounts of cytosolic SIINFEKL because of cotranslational liberation of SIINFEKL by cellu lar ubiquitin hydrolases (or an irrelevant control virus ex pressing VenuseYFP but lacking SIINFEKL; Table I ; Fruci et al., 2003; Lev et al., 2010) . We removed DLN 6 hpi and mea sured expression of K b SIINFEKL on dissociated cells by flow cytometry using a fluorescent conjugate of the TCRlike OTI cells produced IFN at 2 d after infection when restim ulated with SIINFEKL peptide (compared with <0.2% when stimulated with an irrelevant peptide; Fig. 4 , F and G). In CD11cdepleted mice, however, <8% of cells produced IFN in response to SIINFEKL peptide, and even cells that had di vided 5 times synthesized less IFN on average. DTx treatment did not modify IFN production in non-DTR transgenic (C57BL/6) mice (unpublished data).
A hallmark of effector CD8 + cells is their ability to traffic from LNs to peripheral infection sites. We transferred OTI cells into CD11cDTReGFP mice treated with DTx or untreatedmice and infected intradermally in the ear with VVSIINFEKL. 4 d later, ears were removed and examined for the presence of OTI cells (Fig. 4, H and I) . Remarkably, macrophageprimed OTI cells from DTxtreated mice completely failed to traffic to the infection site.
Together, these data indicate that macrophageprimed CD8 + T cells exhibit diminished proliferation, altered activa tion, and greatly reduced functionality, pointing to the im portance of DCmediated activation in this system.
DC-ablated LNs still present viral antigen
Several possible explanations exist for the altered priming in DTxtreated CD11cDTReGFP mice, the simplest of infection, forming stable contacts with virusinfected cells in the presence of cognate antigen (Hickman et al., 2008) . No tably, in the absence of specific antigen, CD8 + T cells in the periphery move at reduced speeds compared with those in the deeper T cell zone, yet fail to form immotile, stable con tacts with non-antigenexpressing APCs. To analyze T cell behavior in DCablated mice, we transferred 10 7 OTI cells into CD11cDTReGFP mice, treated mice with DTx, in fected with VVSIINFEKL 12 h later, and imaged the DLN 6 hpi after injection of fluorescent dextran to identify macro phages (Fig. 6, A and B and Video 6). Remarkably, in DTx treated mice, 82% of OTI cells localized to the MRR compared with 18% in untreated mice. Complete T cell acti vation requires stable prolonged contact between T cells and APCs (Mempel et al., 2004; Henrickson et al., 2008) . MPM revealed that most OTI cells in the MRR of DTxtreated mice were relatively immotile throughout antibody 25D1.16 (Fig. 5 E) . Cells from both untreated and DTxtreated mice were specifically stained with 25D1.16, demonstrating that APCs in DTxtreated mice are able to generate class I peptide complexes from endogenous antigens, although at lower levels than in untreated mice.
Collectively, these data demonstrate that medullary macro phages are infected in DTXtreated mice and infected cells still robustly present antigen in the node, albeit at lower numbers and antigen levels than in untreated mice.
CD8 + T cells establish stable interactions with infected macrophages in the absence of DCs
How do CD8 + T cells behave in the absence of DCs? In DC competent mice, T cells rapidly transit to the periphery after the protein levels of several chemokines on excised nodes. VV infection increased levels of 5 chemokines examined at 6 hpi, with all except CCL3 being significantly greater at 12 hpi (Fig. 8) . The greatest increases were seen with CCL2 and CCL4. We confirmed VV induction of CCL3 expres sion in BMDCs (unpublished data).
the course of three consecutive 20min imaging sessions (the first of which is shown in Video 7). To image the inter action between OTI cells and infected macrophages, we transferred OTI cells into mice 12 h before DTx treatment, and then infected them with VVNPSeGFP. 6-10 hpi, we imaged OTI cells interacting with VVinfected cells in the DLN (Fig. 6 C and Video 8) . In both control and DTx treated mice, OTI cells formed numerous tight contacts with infected cells. DTx treatment had no significant effect on the mean contact time (27 min in each case during a 30min imaging period), arrest coefficients (the fraction of time OTI cells paused on infected cells), or mean T cell speeds (Fig. 6, C-H) .
Collectively, these data demonstrate that in the absence of DCs, OTI cells migrate into the MRR and form contacts with VVinfected macrophages that are grossly indistinguish able from their contacts with infected DCs.
CD8 + T cells rapidly scan infected non-DCs
Although T cells can form stable contacts with macrophages when DCs are absent, we reasoned that the presence of DCs could significantly impact the nature of contacts between T cells and macrophages. Therefore, we next used MPM to analyze contacts in CD11ceYFP mice between T cells and DCs or macrophages 6 h after VV infection. Over a 20min imaging period, we tracked T cells moving among infected (directpriming) DCs, uninfected DCs (which likely con sisted of crosspriming DCs and those expressing amounts of fluorescent proteins below detectable levels), and infected nonDCs (macrophages; Fig. 7 A) . Although there was no clear difference in the speed of T cells interacting with in fected and uninfected DCs (1.4 µm/min, similar to values for previously unidentified infected cells; Hickman et al., 2008) , T cells interrogated infected nonDCs at a signifi cantly higher speed (Fig. 7 B) . Likewise, T cells closely scanned DCs in a curved path, but moved in straighter lines (indicated by higher track linearity) when interacting with infected nonDCs (Fig. 7 C) . Finally, we monitored T cell arrest over a 30min period for T cells interacting with each APC cate gory (Fig. 7 D) . T cells arrested for similar periods over in fected and uninfected DCs, but paused for shorter amounts of time over nonDCs.
Overall, these data indicate that T cells preferentially form stable contacts with DCs (whether overtly infected or not) over infected macrophages. macrophages and DCs in the LN parenchyma (Hickman et al., 2008) . Because viral peptides are generated primarily from DRiPs (Dolan et al., 2011) , the onset of viral protein synthesis is immediately accompanied by the generation of class I peptide complexes, which can rapidly initiate CD8 + T cell priming. For VV, the initial phase of direct priming likely persists for 12-24 h (Hickman et al., 2008) , after which infected DCs and macrophages succumb to viral cytopatho genesis or NKmediated lysis. Because the first 12 hpi are critical for activating antiviral T cells after s.c. VV infection (Hickman et al., 2008) , it is imperative that T cells rapidly contact the appropriate infected APC.
The second wave of antigen presentation likely involves transfer or acquisition of antigen by LNresident APCs. CD8 + DCs are particularly adept at crosspriming antigens acquired from dead or dying cells (den Haan et al., 2000; Iyoda et al., 2002) . For viruses that infect dermal epithelial cells, like herpes simplex virus1, these cells provide an anti gen source for crosspriming by migratory dermal DCs (Bedoui et al., 2009 ). To date, antiviral crosspriming has been investigated largely by ex vivo analyses of cells recov ered from dissociated tissues (Allan et al., 2003; Belz et al., 2004; Bedoui et al., 2009 ). It will be important in future studies to confirm the central role of CD8 + DCs in antiviral crosspriming using MPM, although it will be challenging to unambiguously identify APCs actively engaged in cross priming and not direct priming after synthesis of undetect able levels of viral antigens.
The LN CR, a reticular stromal structure at the border of the T/B zones, likely serves as a staging ground for both direct and crosspriming T cell-APC interactions (Katakai et al., 2004) . Migratory, antigenbearing DCs are thought to accumulate in the CR, positioning themselves to maximize crosspriming interactions with nearby T cells (Bajénoff et al., 2003; Lindquist et al., 2004) . We show here that direct priming interactions in dependent of DC migration also occur in the outermost edges of the CR as virions drain to the LN and are captured by resident APCs. After the first wave of virusinfected cells die or are elimi nated in the LN, it will be interesting to determine the location of virusspecific CD8 + T cell-APC interactions in relation to the macrophagerich and dendritic regions of the CR.
Controversy swirls around the definition of macrophages versus DCs and their putative differences in priming capacity.
Chemokine-neutralizing Abs impair the primary CD8 + T cell response to V V Do VVinduced chemokines play an essential role in attract ing CD8 + T cells to DCs during viral infection? Remarkably, administering a cocktail of neutralizing Abs against CCL3, CCL4, and CCL5 dramatically redistributed OTI cells from DCs into the MRR (Fig. 9) , which is visualized clearly using either twocolor (red T cells, green macrophages; Fig. 9 A) or threecolor MPM (blue CD8 + T cells, green DCs, and red macrophages; Fig. 9 C and Video 9). In untreated mice, 30% of OTI cells were associated with MRR macro phages, but in mice treated with antiCCL3, CCL4, and CCL5 Abs, >60% of OTI cells localized in the MRR (Fig. 9 B) . s.c. injection of recombinant CCL3 (introducing artificial gradients of CCL3 in the uninfected node) also in duced T cell scanning of both DCs and the MRR early after VV infection (Fig. 9 , D and E and Video 10). Additionally, CCR5KO OTI cells failed to form large clusters with VVinfected cells at 6 hpi ( Fig. 9 F) , and many of the cells were located in the MRR (visualized using the natural autofluorescence of the region; Fig. 9 G and Video 11).
We examined the participation of these chemokines in regulating antiviral immune responses via APC selection by s.c. injecting a mixture of CCL3, CCL4, and CCL5blocking Abs at the time of infection. Chemokine neutralization re duced OTI CD69 induction (an early indicator of activation) 15 hpi with VVOva (Fig. 9 H) , and decreased IFN synthe sis 2 d after infection (Fig. 9 I) . In contrast, injection of iso typecontrol Abs did not impact T cell activation (unpublished data). In untreated, infected LNs, CCR5KO OTI cells (lacking the CCR5 receptor for these chemokines, but retaining CCR1 which also signals via several CCR5 ligands) upregulated CD69 to a lesser extent than WT OTI cells (Fig. 9 J) .
Together, these findings demonstrate that the chemokines CCL3, CCL4, and CCL5 play essential roles in enabling T cells to reach a complete effector differentiation state and maximizing primary antiviral CD8 + T cell responses by enhanc ing CD8 + T cell interactions with DCs in the infected node.
DISCUSSION
After s.c. delivery of infectious virions, the most rapid anti gen presentation occurs via direct priming. Within seconds, lymphatics convey virions to LNs, where they can infect Additionally, LN depletion of CD11c + cells, which elimi nates nearly all DCs and SCS macrophages, has profound effects on antiviral priming, despite our direct observations that CD8 + T cells now form contacts with macrophages that are indistinguishable by IVM from their contacts with DCs under nonablative conditions. This argues strongly that DCs have a unique role in direct priming that macrophages can not replace. Hume (2008) has eloquently argued that DCs are simply mononuclear phagocytes that do not comprise a unique cel lular subset, and are not especially adept at priming. A key element of Hume's argument is that the heightened prim ing ability of DCs relative to macrophages ex vivo is caused by removing suppressive macrophages during the process of isolating DCs. Here, we show that in vivo, T cells scan DCs and macrophages at different rates in infected LNs. 
MATERIALS AND METHODS
Mice. Specific pathogen-free CD11cDTReGFP transgenic mice on a C57BL/6 background were acquired from The Jackson Laboratory (stock # 4509) and bred in house. Nontransgenic WT controls were C57BL/6 mice. CD11ceYFP mice (Lindquist et al., 2004) were acquired through the National Institute for Allergy and Infectious Disease (NIAID) Intramural Research Repository and are now available from The Jackson Laboratory (stock# 8829). CCR5KO mice (The Jackson Laboratory; stock #5427) were crossed to OTI TCR transgenic mice (acquired through the NIAID Intramural Research Repository) and bred for homozygosity. 6-16wkold adult mice were used in all experiments. All mice were housed under spe cific pathogen-free conditions (including MNV, MPV, and MHV) and maintained on standard rodent chow and water supplied ad libitum. All ani mal procedures were approved by and performed in accordance with the NIAID Animal Care and Use Committee. DC depletion and adoptive transfer. DC depletion was performed as described previously (Jung et al., 2002) . Mice were given a single of dose of DTx at 4 ng/g body weight (SigmaAldrich) i.p. in PBS unless another dose is noted. CD8 + T cells (TCR transgenic) were transferred 12 h before deple tion. Virus infections were always performed 12-24 h after DTx administra tion, allowing complete DC depletion before infection. Mice received only one dose of DTx.
Dextran and virus injection.
Approximately 25 µg of FITC or tetra methylrhodamineconjugated 70 kD dextran (Invitrogen) was injected s.c. 30-45 min before LN analysis where indicated. VV was injected s.c. (3.5 × 10 7 PFU) or footpad (10 4 PFU) in sterile saline. Route of infection is indicated for each figure. Previously described VVs used in this study include the fol lowing: VVOva, VVNPSeGFP, VVSIINFEKL, VVVenusubiquitin SIINFEKL, VVVenusubiquitinNP 366374 (Norbury et al., 2002; Norbury et al., 2004; Lev et al., 2008) . VVNPSmCherry was constructed accord ing to established protocols (Earl et al., 2001 ).
Adoptive transfers. CD8 + T cells were purified from TCRtransgenic rag / mice by negative selection using magneticactivated cell sorting (MACS) according to the manufacturer's instruction (Miltenyi Biotec). Cells were 95-99% pure by flow cytometry. Purified cells were labeled with 2 µM CFSE (Invitrogen) for 10 min at room temperature in PBS. For IVM, cells were labeled with 2 µm CMPTX or CMF 2 HC (Invitrogen). The amount of T cells transferred is indicated in specific figure legends.
Confocal whole-mount microscopy. Whole LNs were removed at in dicated time points after infection and placed in 3.2% paraformaldehyde for 2 h at 4°C. For CD11ceYFP experiments, mice were given 10 7 CMF 2 HC labeled (blue) OTI cells 12 h before infection. Where indicated, mice were given lysinefixable fluorescent dextran s.c. (Invitrogen) 30-45 min before removal. Nodes were washed extensively in PBS, and then stained overnight with antiCD11b (clone M1/70; eBioscience) conjugated to Alexa Fluor 647, or for 2 h with antiF4/80 (clone BM8; eBioscience). Nodes were washed in PBS before slicing into smaller pieces, which were mounted on slides in Fluoromount G (Electron Microscopy Sciences). Slides were im aged on an SP5 confocal microscope (Leica).
Ex vivo analyses of dissociated LNs. For flow cytometric determination of the nature and number of infected cells per node, untreated or CD11cDTR eGFP mice treated with DTx were given 3.5 × 10 7 PFU VVNPSmCherry 8-12 h before removal of inguinal LNs. Singlecell suspensions were gener ated via digestion in collagenase (Worthington Biochemical Corporation) + dispase (Roche) before staining for CD11c, CD11b, CD169, F4/80, and GR1. Cells were gated on mCherry + vacciniainfected cells before addi tional analyses of individual cell populations.
For determination of the nature and number of dextran + cells, mice were given 0.25 µg FITCconjugated 70 kD dextran 30-45 min before node removal and digestion with collagenase + dispase. Singlecell suspensions What is the role for the large numbers of infected LN macrophages if not for priming naive CD8 + T cells? Re cently, Asano et al. (2011) showed that these macrophages serve as facile APCs via crosspresentation of tumor associated antigens, making their failure to drive antiviral T cell responses even more enigmatic. Several imaging studies have now shown antigen acquisition by SCS sinus macrophages and subsequent antigen donation to LN B cells (Batista and Harwood, 2009) . Perhaps virally infected nodal macrophages specialize in presentation to B cells and are largely ignored by T cells (much like CD8 + DCs preferentially present to CD8 + and not CD4 + T cells; Dudziak et al., 2007) . Additionally, these macrophages express the molecule sialoadhesin, a newly identified participant in regulatory T cell function and expan sion, raising the possibility that macrophage infection activates suppressive rather than effector T cells (Wu et al., 2009) .
We show that macrophages prime CD8 + T cells that are suboptimally activated by the standard criteria. It remains to be determined, however, whether there is method to this madness and the "partially" activated cells are fully activated for a specific alternative function in primary or memory re sponses. Alternatively, macrophages may serve to dampen initial CD8+ T cell responses generated via direct priming, favoring instead crosspriming at later time points. In any event, it is a safe assumption that macrophages perform mul tiple functions in the infected LNs.
In clearly demonstrating the essential role DCs play in di rect antiviral priming, our findings emphasize the importance of understanding the basis for CD8 + T cell attraction to in fected PIR DCs. This knowledge is likely to be useful in maxi mizing the ability of vaccines to elicit effective CD8 + T cell responses. We provide the initial evidence that CCR5 and R1 signaling chemokines, known to guide CD8 + T cells to cross priming DCs in noninfectious models (Castellino et al., 2006; Hugues et al., 2007) , also play a critical role in direct priming during viral infection. We show, first, that viruses rapidly in duce chemokines in the LN, and second, that an Ab cocktail that neutralizes several of the known CCR5 ligands inhibits both DC attraction of CD8 + T cells and CD8 + T cell IFN responses. Additionally, these experiments likely underestimate the importance of CCR5 agonist chemokines in direct anti viral CD8 + T cell priming, since it is unlikely that the Ab cock tail we used covers all CCR5 agonists or completely neutralizes the agonists covered. Likewise, experiments using CCR5KO OTI cells will similarly undervalue the effect of these che mokines on CD8 + T cell responses as the cells retain signaling through CCR1-CCL3 and -CCL5 interactions.
Because of its relevance for rational vaccine design, there is tremendous interest in identifying APC types that most effectively prime functional CD8 + T cell responses. We have identified a factor that optimizes CD8 + T cell targeting to appropriate APCs during viral infection. This raises the excit ing possibility of engineering vaccines to express optimal an tigens as well as a guidance system to attract CD8 + T cells to DCs for maximal priming of effector cells with optimal effec tor profiles.
Bioplex assay. LN chemokines were analyzed during infection using a beadbased assay (Bioplex; BioRad Laboratories) and results were read out on a Bioplex Suspension Array System (BioRad Laboratories). Experi ments were basically performed according to the manufacturer's instruc tions. To gain more reproducible virus drainage to the LN, we analyzed cytokines within the popliteal LN instead of the inguinal. Mice were infected for various time points with VVNPSeGFP (10 4 PFU footpad), and the skindraining popliteal LN was removed and placed 250 µl buffered saline solution with 0.1% BSA. Two nodes were pooled for a single sam ple. LNs were homogenized in solution, and samples were centrifuged at 14,000 g for 6 min to remove cellular debris. Exactly 100 µl of clarified supernatant was used per sample, and samples performed in duplicate. Results were analyzed using GraphPad Prism Software Version 5.0 (Graph Pad). Error bars represent SEM, and groups compared using unpaired Student's t tests. Chemokine-neutralizing Abs and recombinant chemokine injection. 50 µg each of antiCCL3 (MAB450), antiCCL4 (MAB451), and anti CCL5 (MAB478; all from RND Systems) were given i.v. in sterile saline at the same time as infection. Alternatively, 150 µg rat IgG2a (BioXcell) was given in the same manner. 1 µg of rCCL3 (R&D Systems) in sterile saline was given s.c. 45 min to 1 h before imaging. CFSE proliferation. Spleens, inguinal, brachial, cervical, and mesenteric LNs were removed and homogenized to produce singlecell suspensions. Red blood cells were lysed, and samples were filtered through a 70µm nylon filter. Cells were labeled for 10 min at room temperature in 2 µM CFSE (Invitrogen). 5 × 10 6 OTI cells were transferred i.v. into CD11cDTReGFP mice, which were treated with DTx or PBS i.p. 12 h later, mice were infected s.c. with 3.5 × 10 7 PFU VVNPSeGFP. 48 hpi, inguinal nodes were re moved and analyzed by flow cytometry. OTI cells were stained for CD45.1 (clone A20) and CD8 (clone 53-6.7) from eBioscience as well as propidium iodide, and analyzed for CFSE fluorescence on a BD LSRII flow cytometer (BD). Proliferation was then examined using FlowJo (Tree Star).
OT-I cellular activation assays. 12 h before infection s.c. with 3.5 × 10 7 PFU VVovalbumin, 5 × 10 6 OTI cells were transferred i.v. into WT mice. For activation marker analysis, OTI cells were removed from the draining ILN at indicated time points after infection using homogenization. Red bloods cells were lysed, and samples were filtered through a 70 µm nylon fil ter. Singlecell suspensions were stained for CD69 (clone H1.2F3), CD25 (clone PC61), CD62L (clone Mel14), CD45.1 (clone A20), and CD8 (clone 53-6.7; eBioscience). Results were compiled from four independent experiments by normalizing the maximum CD69 MFI per experiment to 100. Where indicated, mice received a single injection of chemokine neutralizing Abs at the same time as infection.
For analysis of IFN production, WT or CD11cDTReGFP mice (indicated in figure legends) were infected s.c. with 2.5 × 10 7 PFU VV ovalbumin or VVNPSeGFP. Where indicated, mice received a single in jection of chemokineneutralizing Abs i.v. concomitant with infection. Inguinal LNs were harvested 48 hpi and homogenized, and cells were resuspended in RPMI10 + 10 mM Hepes buffer and plated at 2 × 10 6 cells/well in Ubottom, 96well plates along with SIINFEKL or an irrelevant control peptide (SSIE FARL) at a final concentration of 100 nM. Cells and peptide were incubated for 3 h. at 37°C in the presence of 10 µg/ml brefeldin A (SigmaAldrich) to were stained for CD11c, CD11b, F4/80, and GR1. Cells were gated on the FITC + population before analyzing individual cell types.
Histochemistry on frozen LN sections. LNs were removed and embed ded in OCT medium (Electron Microscopy Sciences) and frozen in dryice cooled isopentane. 20 µm sections were cut on a Leica cryostat (Leica). Sec tions were fixed in ice coldacetone for 5 min before blocking with 5% goat or donkey serum, then staining with the following Abs: ERTR7 (clone ERTR7; Abcam), CD11b (clone M1/70; eBioscience), F4/80 (clone BM8; eBioscience), CD11c (clone N418; eBioscience), B220 (clone RA3 6B2; eBioscience), pNAd (clone Meca79; BD), CD8 (clone 53-6.7; eBio science), and GR1 (clone RB68C5; eBioscience).
MPM. CD8 + T cells labeled with CFSE, CMTPX (C 42 H 40 ClN 3 O 4 ), or CMF 2 HC (4chloromethyl6,8difluoro7hydroxycoumarin; all from In vitrogen) were injected intravenously 12-24 h before injection with virus, unless otherwise specified. When indicated, mice were given 25 µg FITC or rhodamineconjugated 70kD dextran (Invitrogen) s.c. for drainage to the inguinal LN. Twophoton imaging used an inverted TCSSP2 MP confocal microscope (Leica) equipped with a 20× objective (numerical aperture, 0.7) or 63× objective (numerical aperture, 1.30) and with 80% glycerol as the immersion medium for each objective. Twophoton excitation was pro vided by a Mai Tai Ti:Sapphire laser (Spectra Physics) with a 10Watt pump, tuned to 800 nm for imaging of cells labeled with CMTPX, FITC, or CMF 2 HC; 850 nm for imaging of cells labeled with CMTPX in combina tion with eGFP; or 900 nm for imaging of eGFP alone or for imaging of secondharmonic generation. Emitted fluorescence was collected with a twochannel nondescanned detector. Wavelength separation was accom plished with a dichroic mirror at 560 nm, followed by emission filters of 525/50 nm bandpass and 610/75 nm bandpass. For imaging of cellular inter actions, the 63× objective was used, and stacks of 25 sections obtained with a 2.5µm zstep for a total depth of 40-60 µm were obtained every 30 s.
For imaging of CD11ceYFP LNs after infection, a TCSSP5 MP con focal microscope (Leica) equipped with dual MP lasers was used. One laser was set at 800 nm for imaging dyelabeled cells and CMF 2 HClabeled OTI cells, and the other was set at 900-930 nm for imaging VVNPSmCherry and eYFP. Images were obtained in sequential mode using the same 63× objective as in the previous paragraph. Sections were taken at 2.5µm inter vals for a total depth of 40 µm. Series were acquired every minute.
Data analyses. Data were analyzed with Imaris 64 version 6.1.2 (Bit plane). Images were processed using the Gaussian filter algorithm. Con tact times between VVinfected cells and OTI cells were calculated manually and compiled from 3-5 separate movies for each condition (DTxtreated or WT). Contacts were defined as being in close proximity (<1 µm) from a nuclearexpressed fluorescent protein. Arrest coefficients were calculated using the Imaris XT function "plot length of selected track," and the percentage of pause steps for all of the T cells in a given image were plotted using GraphPad Prism 5. Overlays of tracks were gen erated using Imaris XT function "translate tracks," and then pseudocol ored according to the mean speed of the cell creating the track. Average speeds were calculated using the spotdetection function and the follow ing parameters: autoregressive motion, gapclose 3, 7.5µm object diame ter, 40 µm maximum distance.
The number of infected cells under DTxtreated or untreated condi tions was calculated from 3-6 fields 63× fields (238 × 238 × 85 µms) chosen randomly in 3 separate VVinfected LNs. The percentage of cells in the MRR was calculated by determining the number of OTI cells associated with the MRR compared with the total number of OTI cells in the 63× field. 3-6 fields per LN were selected for the MRR and the zone just outside it (but otherwise randomly); data from at least four individual LNs were compiled. Results were analyzed using GraphPad Prism 5 software. Means are indicated with a solid line and standard error of the mean is shown. Groups were analyzed using an unpaired Student's t test. allow IFN accumulation. For dead cell exclusion, cells were treated with ethidium monoazide (Invitrogen) before washing, incubating with Fc block (antibody 2.4G2 produced in house), and staining with antiCD8 (clone 53-6.7) and antiCD45.1 (clone A20; eBioscience). After staining, cells were washed and fixed at room temperature for 20 min with 1% paraformal dehyde. Cells were next incubated overnight at 4°C with Alexa Fluor 647 anti-IFN (clone XMG1.2, eBioscience) diluted in PBS containing 0.5% saponin (EMD Biosciences). Cells were analyzed on a BD LSR II and the MFI of IFN signal normalized to the maximum MFI in a given experi ment. Results were compiled from three individual experiments. 
